PPARA and cystic fibrosis: In conclusion, our study revealed that both the expression and activity of PPARα, a transcription factor with anti-inflammatory capacities, is down-regulated in peripheral lymphocytes of CF patients, which may render lymphocytes into cells that promote the inflammatory response and consequently lead to increased inflammation.